{"organizations": [], "uuid": "8e4962eacd4c84828f2344c01485290a154c22ae", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-teva-pharm-says-on-track-with-spen/brief-teva-pharm-says-on-track-with-spending-cuts-idUSL8N1PY5VA", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva Pharm says on track with spending cuts", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-08T21:06:00.000+02:00", "replies_count": 0, "uuid": "8e4962eacd4c84828f2344c01485290a154c22ae"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-teva-pharm-says-on-track-with-spen/brief-teva-pharm-says-on-track-with-spending-cuts-idUSL8N1PY5VA", "ord_in_thread": 0, "title": "BRIEF-Teva Pharm says on track with spending cuts", "locations": [], "entities": {"persons": [{"name": "tova cohen", "sentiment": "none"}, {"name": "ari rabinovitch", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-teva pharm", "sentiment": "negative"}, {"name": "teva", "sentiment": "negative"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "negative"}, {"name": "teva pharm", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Teva Pharmaceutical Industries Ltd :\n* TEVA PHARM: EXPECTS TO IMPLEMENT HALF OF 14,000 PLANNED JOB CUTS BY END OF Q2 2018\n* TEVA PHARM: EXPECTS TO ANNOUNCE ADDITIONAL 6 PLANT CLOSURES OR DIVESTMENTS BY END OF 2018 FOR TOTAL OF 12\n* TEVA PHARM: 25 SPECIALTY DRUG PROGRAMS AND MORE THAN 100 GENERICS PROGRAMS DISCONTINUED\n* TEVA PHARM SAYS ON TRACK TO ACHIEVE MORE THAN HALF OF PLANNED $3 BILLION IN SPENDING CUTS IN 2018, FULLY IN 2019 Further company coverage: (Reporting by Ari Rabinovitch; Editing by Tova Cohen)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T21:06:00.000+02:00", "crawled": "2018-02-09T16:49:48.030+02:00", "highlightTitle": ""}